Derma Sciences

Derma Sciences is a Medical Devices company specializing in the field of Advanced Wound Care. Currently their major products are Medihoney, Algicell AG, Xtrasorb wound dressing, Bioguard and Mobility1. Their newest product DSC127 - an Angiotensin Analog - is currently in Phase II Pre-Clinical trials.
Parent Company
Integra LifeSciences
Princeton, US
Derma Sciences was founded in 1984 and is headquartered in Princeton, US

Key People at Derma Sciences

John E. Yetter

John E. Yetter

CFO & Vice President of Finance
Srini Conjeevaram

Srini Conjeevaram


Derma Sciences Office Locations

Derma Sciences has offices in Princeton and New York
Princeton, US (HQ)
300 214 Carnegie Center
New York, US
800 3rd Ave

Derma Sciences Data and Metrics

Derma Sciences Summary

Founding Date


Total Funding

$29.1 m
Derma Sciences is a subsidiary of Integra LifeSciences

Derma Sciences Financial Metrics

Derma Sciences's revenue was reported to be $84.5 m in FY, 2015 which is a 1% increase from the previous period.
USDFY, 2013FY, 2014FY, 2015


79.7 m83.7 m84.5 m

Revenue growth, %


Cost of goods sold

50.3 m53.6 m51.7 m

Gross profit

29.4 m30.1 m32.7 m
USDFY, 2013FY, 2014FY, 2015


6.5 m19.4 m15.8 m

Accounts Receivable

7.3 m8.8 m8.1 m


16.5 m13.3 m20.7 m

Current Assets

49.5 m100.8 m71.1 m
USDFY, 2013FY, 2014FY, 2015

Net Income

(24 m)(39.8 m)(38.1 m)

Accounts Receivable

(266.8 k)(1.4 m)324.2 k


(3 m)2.6 m(9.1 m)

Accounts Payable

574.3 k679.9 k(1.6 m)
Show all financial metrics

Derma Sciences Operating Metrics

FY, 2015

Patents (US)

Show all operating metrics

Derma Sciences Revenue Breakdown

Traffic Overview of Derma Sciences

Derma Sciences Online and Social Media Presence

Derma Sciences News and Updates

BRIEF-Derma Sciences to acquire BIOD

* Derma Sciences to acquire BIOD, solidify its leadership position in advanced wound care and regenerative products

Derma Sciences Company Life and Culture

You may also be interested in